Medical Molecular Morphology

, Volume 47, Issue 4, pp 213–223 | Cite as

Renal atrophy after ischemia–reperfusion injury depends on massive tubular apoptosis induced by TNFα in the later phase

  • Takaomi Adachi
  • Noriyuki Sugiyama
  • Hideo Yagita
  • Takahiko Yokoyama
Original Paper

Abstract

Recent studies have suggested that acute kidney injury (AKI) develops into chronic kidney disease (CKD). However, a mechanism for disease progression from AKI to CKD has not been established. We developed two ischemia–reperfusion injury (IRI) mouse models, a repaired kidney model and an atrophic kidney model, and studied the mechanisms of renal atrophy after IRI by comparing the two models. We found that renal atrophy after IRI depended on tubular apoptosis at 14 days after IRI. Moreover, we found that Tnfα and FasL mRNA were synchronously expressed at the time of tubular apoptosis. To elucidate the relationship between tubular apoptosis and apoptotic ligands, we administered TNFα and FasL neutralizing antibodies according to the time of tubular apoptosis. TNFα blockade significantly repressed tubular apoptosis, resulting in the prevention of renal atrophy. FasL blockade could not repress tubular apoptosis, resulting in renal atrophy. We also found that TNF receptors were expressed in the kidney at 14 days after IRI, but Fas receptor was not. We concluded that renal atrophy after IRI depends on tubular apoptosis induced by the TNFα signaling pathway in the later phase of renal IRI, and that TNFα blockade could be a potential new therapeutic approach for improving renal prognosis after AKI.

Keywords

TNFα Apoptosis Atrophy Ischemia–reperfusion injury 

Notes

Acknowledgments

This work was supported by a Grant-in-Aid for Scientific Research (C, 23591197) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.

Conflict of interest

None.

Supplementary material

795_2013_67_MOESM1_ESM.pdf (2.3 mb)
Supplementary material 1 Fig. 1 Relationship between the duration of ischemia and kidney phenotypes after IRI. a Body weights of each IRI group (sham, 30, 45, 60, and 90 min) at 28 days after IRI (sham, 30, 90 min: n = 3; 45, 60 min: n = 8). The body weights showed no differences by ischemic interval. b Time-course of KW/BW of IRI45 and sham (IRI45: n = 8, sham: n = 3). There was no difference between IRI45 and sham in the time-course of KW/BW. c Histological change at 56 days after IRI45 and IRI60 as estimated by PAS staining (bar 50 μm). d Time-course of serum creatinine in IRI45 and IRI60 (n = 3). Fig. 2 PAS stained section of kidneys in IRI45 and IRI60 at 0, 1, 3, 7, 14, and 28 days after IRI (bar 100 μm) (PDF 2362 kb)

References

  1. 1.
    Himmelfarb J, Ikizler TA (2007) Acute kidney injury: changing lexicography, definitions, and epidemiology. Kidney Int 71(10):971–976PubMedCrossRefGoogle Scholar
  2. 2.
    Xue JL, Daniels F, Star RA, Kimmel PL, Eggers PW, Molitoris BA, Himmelfarb J, Collins AJ (2006) Incidence and mortality of acute renal failure in medicare beneficiaries, 1992 to 2001. J Am Soc Nephrol 17:1135–1142PubMedCrossRefGoogle Scholar
  3. 3.
    Coca SG, Yusuf B, Shlipak MG, Garg AX, Parikh CR (2009) Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 53:961–973PubMedCentralPubMedCrossRefGoogle Scholar
  4. 4.
    Lo LJ, Go AS, Chertow GM, McCulloch CE, Fan D, Ordonez JD, Hsu CY (2009) Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease. Kidney Int 76:893–899PubMedCentralPubMedCrossRefGoogle Scholar
  5. 5.
    Chawla LS, Amdur RL, Amodeo S, Kimmel PL, Palant CE (2011) The severity of acute kidney injury predicts progression to chronic kidney disease. Kidney Int 79:1361–1369PubMedCentralPubMedCrossRefGoogle Scholar
  6. 6.
    Finn WF (1980) Enhanced recovery from postischemic acute renal failure. Micropuncture studies in the rat. Circ Res 46:440–448PubMedCrossRefGoogle Scholar
  7. 7.
    Perico N, Cattaneo D, Sayegh MH, Remuzzi G (2004) Delayed graft function in kidney transplantation. Lancet 364:1814–1827PubMedCrossRefGoogle Scholar
  8. 8.
    Linkermann A, Brasen JH, Himmerkus N, Liu S, Huber TB, Kunzendorf U, Krautwald S (2012) Rip1 (receptor-interacting protein kinase 1) mediates necroptosis and contributes to renal ischemia/reperfusion injury. Kidney Int 81:751–761PubMedCrossRefGoogle Scholar
  9. 9.
    Bonventre JV, Yang L (2011) Cellular pathophysiology of ischemic acute kidney injury. J Clin Investig 121:4210–4221PubMedCentralPubMedCrossRefGoogle Scholar
  10. 10.
    Bonegio R, Lieberthal W (2002) Role of apoptosis in the pathogenesis of acute renal failure. Curr Opin Nephrol Hypertens 11:301–308PubMedCrossRefGoogle Scholar
  11. 11.
    Ortiz A, Justo P, Sanz A, Lorz C, Egido J (2003) Targeting apoptosis in acute tubular injury. Biochem Pharmacol 66:1589–1594PubMedCrossRefGoogle Scholar
  12. 12.
    Saikumar P, Venkatachalam MA (2003) Role of apoptosis in hypoxic/ischemic damage in the kidney. Semin Nephrol 23:511–521PubMedCrossRefGoogle Scholar
  13. 13.
    Donnahoo KK, Meng X, Ao L, Ayala A, Shames BD, Cain MP, Harken AH, Meldrum DR (2001) Differential cellular immunolocalization of renal tumour necrosis factor-alpha production during ischaemia versus endotoxemia. Immunology 102:53–58PubMedCentralPubMedCrossRefGoogle Scholar
  14. 14.
    Daemen MA, van de Ven MW, Heineman E, Buurman WA (1999) Involvement of endogenous interleukin-10 and tumor necrosis factor-alpha in renal ischemia–reperfusion injury. Transplantation 67:792–800PubMedCrossRefGoogle Scholar
  15. 15.
    Nogae S, Miyazaki M, Kobayashi N, Saito T, Abe K, Saito H, Nakane PK, Nakanishi Y, Koji T (1998) Induction of apoptosis in ischemia–reperfusion model of mouse kidney: possible involvement of fas. J Am Soc Nephrol 9:620–631PubMedGoogle Scholar
  16. 16.
    Hamar P, Song E, Kokeny G, Chen A, Ouyang N, Lieberman J (2004) Small interfering rna targeting fas protects mice against renal ischemia–reperfusion injury. Proc Natl Acad Sci USA 101:14883–14888PubMedCentralPubMedCrossRefGoogle Scholar
  17. 17.
    Du C, Wang S, Diao H, Guan Q, Zhong R, Jevnikar AM (2006) Increasing resistance of tubular epithelial cells to apoptosis by shrna therapy ameliorates renal ischemia–reperfusion injury. Am J Transpl 6:2256–2267CrossRefGoogle Scholar
  18. 18.
    Ko GJ, Jang HR, Huang Y, Womer KL, Liu M, Higbee E, Xiao Z, Yagita H, Racusen L, Hamad AR, Rabb H (2011) Blocking Fas ligand on leukocytes attenuates kidney ischemia–reperfusion injury. J Am Soc Nephrol 22:732–742PubMedCentralPubMedCrossRefGoogle Scholar
  19. 19.
    Sugiyama N, Yokoyama T (2006) Sustained cell proliferation of renal epithelial cells in mice with inv mutation. Genes Cells 11:1213–1224PubMedCrossRefGoogle Scholar
  20. 20.
    Shimizu A, Yamanaka N (1993) Apoptosis and cell desquamation in repair process of ischemic tubular necrosis. Virchows Arch 64:171–180CrossRefGoogle Scholar
  21. 21.
    Al-Lamki RS, Wang J, Skepper JN, Thiru S, Pober JS, Bradley JR (2001) Expression of tumor necrosis factor receptors in normal kidney and rejecting renal transplants. Lab Investig J Tech Methods Pathol 81:1503–1515CrossRefGoogle Scholar
  22. 22.
    Aten J, Roos A, Claessen N, Schilder-Tol EJ, Ten Berge IJ, Weening JJ (2000) Strong and selective glomerular localization of cd134 ligand and tnf receptor-1 in proliferative lupus nephritis. J Am Soc Nephrol 11:1426–1438PubMedGoogle Scholar
  23. 23.
    Tsuruya K, Ninomiya T, Tokumoto M, Hirakawa M, Masutani K, Taniguchi M, Fukuda K, Kanai H, Kishihara K, Hirakata H, Iida M (2003) Direct involvement of the receptor-mediated apoptotic pathways in cisplatin-induced renal tubular cell death. Kidney Int 63:72–82PubMedCrossRefGoogle Scholar
  24. 24.
    Linkermann A, Himmerkus N, Rolver L, Keyser KA, Steen P, Brasen JH, Bleich M, Kunzendorf U, Krautwald S (2011) Renal tubular fas ligand mediates fratricide in cisplatin-induced acute kidney failure. Kidney Int 79:169–178PubMedCrossRefGoogle Scholar
  25. 25.
    Al-Lamki RS, Wang J, Vandenabeele P, Bradley JA, Thiru S, Luo D, Min W, Pober JS, Bradley JR (2005) Tnfr1- and tnfr2-mediated signaling pathways in human kidney are cell type-specific and differentially contribute to renal injury. Faseb J 19:1637–1645PubMedCrossRefGoogle Scholar
  26. 26.
    Vielhauer V, Stavrakis G, Mayadas TN (2005) Renal cell-expressed tnf receptor 2, not receptor 1, is essential for the development of glomerulonephritis. J Clin Investig 115:1199–1209PubMedCentralPubMedCrossRefGoogle Scholar
  27. 27.
    Ramesh G, Reeves WB (2003) Tnfr2-mediated apoptosis and necrosis in cisplatin-induced acute renal failure. Am J Physiol 285:F610–F618Google Scholar
  28. 28.
    Guo G, Morrissey J, McCracken R, Tolley T, Klahr S (1999) Role of tnfr1 and tnfr2 receptors in tubulointerstitial fibrosis of obstructive nephropathy. Am J Physiol 277:F766–F772PubMedGoogle Scholar
  29. 29.
    Fang L, Fang J, Chen CQ (2001) Tnf receptor-associated factor-2 binding site is involved in tnfr75-dependent enhancement of tnfr55-induced cell death. Cell Res 11:217–222PubMedCrossRefGoogle Scholar
  30. 30.
    Misseri R, Meldrum DR, Dinarello CA, Dagher P, Hile KL, Rink RC, Meldrum KK (2005) Tnf-alpha mediates obstruction-induced renal tubular cell apoptosis and proapoptotic signaling. Am J Physiol 288:F406–F411Google Scholar
  31. 31.
    Zhang X, Zheng X, Sun H, Feng B, Chen G, Vladau C, Li M, Chen D, Suzuki M, Min L, Liu W, Garcia B, Zhong R, Min WP (2006) Prevention of renal ischemic injury by silencing the expression of renal caspase 3 and caspase 8. Transplantation 82:1728–1732PubMedCrossRefGoogle Scholar
  32. 32.
    Hotta K, Sho M, Yamato I, Shimada K, Harada H, Akahori T, Nakamura S, Konishi N, Yagita H, Nonomura K, Nakajima Y (2011) Direct targeting of fibroblast growth factor-inducible 14 protein protects against renal ischemia reperfusion injury. Kidney Int 79:179–188PubMedCrossRefGoogle Scholar
  33. 33.
    Conlon PJ, Stafford-Smith M, White WD, Newman MF, King S, Winn MP, Landolfo K (1999) Acute renal failure following cardiac surgery. Nephrol Dial Transpl 14:1158–1162CrossRefGoogle Scholar
  34. 34.
    Gwinner W, Hinzmann K, Erdbruegger U, Scheffner I, Broecker V, Vaske B, Kreipe H, Haller H, Schwarz A, Mengel M (2008) Acute tubular injury in protocol biopsies of renal grafts: prevalence, associated factors and effect on long-term function. Am J Transpl 8:1684–1693CrossRefGoogle Scholar
  35. 35.
    Siew ED, Peterson JF, Eden SK, Hung AM, Speroff T, Ikizler TA, Matheny ME (2012) Outpatient nephrology referral rates after acute kidney injury. J Am Soc Nephrol 23:305–312PubMedCentralPubMedCrossRefGoogle Scholar
  36. 36.
    Silva LC, Ortigosa LC, Benard G (2010) Anti-TNF-α agents in the treatment of immune-mediated inflammatory diseases: mechanisms of action and pitfalls. Immunotherapy 2(6):817–833PubMedCrossRefGoogle Scholar
  37. 37.
    Gómez-Reino JJ, Carmona L, Valverde VR, Mola EM, Montero MD, BIOBADASER Group (2003) Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report. Arthritis Rheum 48(8):2122–2127PubMedCrossRefGoogle Scholar

Copyright information

© The Japanese Society for Clinical Molecular Morphology 2014

Authors and Affiliations

  • Takaomi Adachi
    • 1
    • 2
  • Noriyuki Sugiyama
    • 1
    • 3
  • Hideo Yagita
    • 4
  • Takahiko Yokoyama
    • 1
  1. 1.Department of Anatomy and Developmental Biology, Graduate School of Medical ScienceKyoto Prefectural University of MedicineKyotoJapan
  2. 2.Division of Nephrology, Department of MedicineKyoto Prefectural University of MedicineKyotoJapan
  3. 3.Division of Life Science, Department of Anatomy and Cell BiologyOsaka Medical CollegeTakatsukiJapan
  4. 4.Department of ImmunologyJuntendo University School of MedicineTokyoJapan

Personalised recommendations